Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth - Test2 - elhamkhani - TriplyDB

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

http://www.wikidata.org/entity/Q33798648

about

Targeting dormant micrometastases: rationale, evidence to date and clinical implications Tumour progression and metastasis Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement Understanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease Progression Metastatic mechanisms in follicular cell-derived thyroid cancer Minimal residual disease and circulating tumor cells in breast cancer Interactions between tumor cells and microenvironment in breast cancer: a new opportunity for targeted therapy The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals Suppression and activation of the malignant phenotype by extracellular matrix in xenograft models of bladder cancer: a model for tumor cell "dormancy"Identification of novel drugs to target dormant micrometastases Metastasis suppressor genes at the interface between the environment and tumor cell growth Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities Matrix rigidity regulates cancer cell growth by modulating cellular metabolism and protein synthesis.Nanoparticle uptake in tumors is mediated by the interplay of vascular and collagen density with interstitial pressure.Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion Dynamic and influential interaction of cancer cells with normal epithelial cells in 3D culture.Human cancers express mutator phenotypes: origin, consequences and targeting.Breast Cancer Metastasis to the Axillary Lymph Nodes: Are Changes to the Lymph Node "Soil" Localized or Systemic?Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs Fibronectin induces epithelial-mesenchymal transition in human breast cancer MCF-7 cells via activation of calpain Zoledronic acid has differential antitumor activity in the pre- and postmenopausal bone microenvironment in vivo Advances in the Knowledge about Kidney Decellularization and Repopulation Nicotine stimulates collagen type I expression in lung via α7 nicotinic acetylcholine receptors.Significance of talin in cancer progression and metastasis.Molecular pathways: niches in metastatic dormancy Binding of CD157 protein to fibronectin regulates cell adhesion and spreading.Synergistic therapeutic effect of cisplatin and phosphatidylinositol 3-kinase (PI3K) inhibitors in cancer growth and metastasis of Brca1 mutant tumors."A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies".An overview of tissue and whole organ decellularization processes.Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells.Prospective identification of glioblastoma cells generating dormant tumors.Structural ECM components in the premetastatic and metastatic niche.OASIS/CREB3L1 is induced by endoplasmic reticulum stress in human glioma cell lines and contributes to the unfolded protein response, extracellular matrix production and cell migration Suppression of mitochondrial complex I influences cell metastatic properties.The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs.Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma Metastatic dormancy and progression in thyroid cancer: targeting cells in the metastatic frontier.Intratumoral drug delivery with nanoparticulate carriers.

P2860

Q26765205-2AFA832A-CF24-42A4-8F14-28320E79ADBB Q26766468-B91ACD6E-A619-4373-A0E9-AA29AE5693B4 Q26797285-6372B9F6-066A-47BA-8B01-63054ED6EE96 Q26829830-4806D866-7A6D-469F-9A03-9773D9C248FC Q26829949-C5686EA9-7B11-4C30-98A7-377746051E2D Q27005646-6EADDDEF-2D94-463C-85FF-5F7F736D0E15 Q27010152-B66A70A3-97C7-4804-B74A-F50538987A82 Q27012888-B8496EDD-995C-4D9A-B7BF-556887A6BFDF Q27025313-B7EAB215-D17F-498D-B5C5-000EDDE719F6 Q28383132-ABC1A65F-103A-4BE7-A1B3-D7615716E7AD Q28383446-8F294237-5FA5-489D-997C-77D3DE6271B9 Q28394296-9C902237-8EFC-4AD5-A8B0-D90BC9939948 Q28394526-66DAB337-190C-4F09-89CB-6FFB2967F4B1 Q28751757-59CFDEF2-3923-45DB-AF06-1F214C8AC98B Q30426836-905BA152-59D4-4273-A390-510D8EF20C2F Q30443689-D61FDEB6-590D-4E73-AE64-207C0FAB6F08 Q30553128-0799512B-3556-4088-B12B-F9F4A2EA5D2A Q30596963-4B210B5B-2DCC-4DBF-8961-6300DE42F83F Q33554201-C91A18E3-D16B-4614-A521-AC1767C8E013 Q33562901-5138DE5F-699C-4F89-A70F-5CEACBE81CB9 Q33609142-9502E057-ABB8-4A37-8BD6-BA72B6FAA69C Q33684769-C6EEB2E5-94AC-407C-85E1-C125180A49F0 Q33692900-0B7865AF-ABED-4D72-AF47-876161560521 Q33747421-16DEB13E-5E38-42C1-A24D-52E7FED396B7 Q33759288-F6366DF0-144D-4601-B301-59298500A620 Q33763551-3F78C2DF-82E0-4A1E-93F7-40CE01E77BD4 Q33838536-F9F7E12A-1E3E-4BD6-9BD2-DBB3FF5F942F Q34075993-69231395-11C5-4FE5-ADD1-FA77B262A6AD Q34107207-FBCE8D61-A7A9-47FA-A09D-FEFED6055A8C Q34122934-9EA250AF-0ED6-4915-9A81-F9ED22BBB119 Q34162830-3035CD20-46E2-46EE-B10A-4DAEBBF9E09F Q34166339-5F72B151-C7D7-4CD1-AD13-FD9717E1337E Q34412360-ACC62E54-2F61-4007-91A8-C0F14991D5C3 Q34521147-614D6E5C-D2F4-4EBB-8670-0696D8350B52 Q34555813-BF787153-ACE0-4265-B7F9-C16252EC7C54 Q34695616-D4AD0251-D43F-44AF-B3F7-35EA9EE87541 Q34784896-4E2726D7-CC34-432D-84D7-8A1AC9D53F8C Q34964472-BC2811B6-D4E6-45C1-89F6-BA56C62B568E Q34975148-89EDC8B6-97C8-41FD-86E2-4A9F7E2B6C53 Q35091415-3A3C6655-B4EC-46A9-86A4-36B79D3F36E0

P2860

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

http://www.wikidata.org/entity/Q33798648

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@ast

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@en

type

label

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@ast

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@en

prefLabel

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@ast

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@en

P1433

Q33798648-AED5CEB3-D602-4203-80D5-D9695FD9F124

P1476

Q33798648-F7AFB487-2819-4843-BB09-69654E49748C

P2093

Q33798648-1D0EA88A-D518-452F-B4E6-8EE915D72C77

Q33798648-6DC724D5-B04D-4D77-8D70-57BACC74FA41

Q33798648-EEEEB2DF-8EBD-41E8-9689-D2B96EDAFC10

P2860

Q33798648-08B23DAC-2E50-488A-8622-26562D3881F5

Q33798648-0B163EA3-EB36-4912-82CC-A69CFD85EE38

Q33798648-0BC99331-58DB-4B0F-8D2B-8D864F0C0CDE

Q33798648-185EEF16-0CA2-4A93-9DB6-3FC8CB7A8AA1

Q33798648-1BFE0E80-13DD-4531-860C-A91282E24056

Q33798648-1C54791B-162C-4B83-8704-38E8FED2ADF7

Q33798648-1C5DA8D4-39A2-4890-BD2D-AA581B4BEE4B

Q33798648-211E04BB-CA07-419A-B904-D97B084B1371

Q33798648-273058AF-606F-4CAF-8141-A7E7BDB1F883

Q33798648-2CFA9FFE-96B1-4F3D-AD4E-BFE09C0B9A70

P304

Q33798648-3A5C9CA6-2248-42D5-A00D-452C03888854

P31

Q33798648-6A039274-39E9-467E-8C4C-68B9FA100412

P356

Q33798648-1367D5C0-5777-4391-A42C-48D6B373253B

P433

Q33798648-3E7F59EE-DF01-4F39-B1B5-1A4D005D54C2

P478

Q33798648-64A23567-C4D7-4BBB-8090-BC040DDCA5CD

P577

Q33798648-5F2FD6F7-B977-4EC2-89E6-52869722B3E2

P5875

Q33798648-6874EEA6-912B-4EB1-92EC-22A147FAE957

P698

Q33798648-A69CBF68-CD21-4334-88F9-BD58951CD0D9

P921

Q33798648-236CD478-CDF8-433B-AC69-DA2F8D0BAB91

P932

Q33798648-477B4D9F-DE6C-4F5E-AE7D-D87E4EE214A4

P356

J.EJCA.2010.02.027

P1433

European Journal of Cancer

P1476

Extracellular matrix: a gatekeeper in the transition from dormancy to metastatic growth

@en

P2093

Ann F Chambers

http://www.w3.org/2001/XMLSchema#string

Dalit Barkan

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Green

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds

Distinct antitumor properties of a type IV collagen domain derived from basement membrane

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche

Seeding and propagation of untransformed mouse mammary cells in the lung

Tensional homeostasis and the malignant phenotype

Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development

Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures

Dissemination and growth of cancer cells in metastatic sites

P304

1181-1188

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EJCA.2010.02.027

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

46

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42371590

http://www.w3.org/2001/XMLSchema#string

P698

20304630

http://www.w3.org/2001/XMLSchema#string

P921

extracellular matrix

P932

2856784

http://www.w3.org/2001/XMLSchema#string